This topic contains a solution. Click here to go to the answer

Author Question: A 43-year-old woman with a strong family history of breast cancer considers tamoxifen for cancer ... (Read 100 times)

jrubin

  • Hero Member
  • *****
  • Posts: 552
A 43-year-old woman with a strong family history of breast cancer considers tamoxifen for cancer prevention. Which assessment finding is a possible contraindication?
 
  1. A history of deep vein thrombosis
  2. Prior hysterectomy
  3. A history of osteoporosis
  4. Hyperlipidemia

Question 2

The nurse would be correct to state that the purpose of angiogenesis inhibitors is to
 
  a. kill existing cancer cells directly.
  b. suppress the formation of new blood vessels in tumors.
  c. enhance the size of collateral vessels.
  d. enhance red cell development in the bone marrow.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Awesome

  • Sr. Member
  • ****
  • Posts: 280
Answer to Question 1

Correct Answer: 1

Answer to Question 2

ANS: B
Angiogenesis inhibitors suppress the formation of new blood vessels, thereby depriving solid tumors of the expanding blood supply they need for continued growth.
Angiogenesis inhibitors cannot kill tumor cells that already exist.
Angiogenesis inhibitors do not enhance collateral vessel or red cell development.




Awesome

  • Sr. Member
  • ****
  • Posts: 280

 

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

Medication errors are more common among seriously ill patients than with those with minor conditions.

Did you know?

The ratio of hydrogen atoms to oxygen in water (H2O) is 2:1.

Did you know?

Autoimmune diseases occur when the immune system destroys its own healthy tissues. When this occurs, white blood cells cannot distinguish between pathogens and normal cells.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library